Spine Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting byTim AllenDecember 3, 2025
Financial Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance byTim AllenNovember 6, 2025
Spine Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary byWill SandbergSeptember 29, 2025
Financial Hospitals Spine Top Stories Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures byJosh SandbergAugust 1, 2025
Spine Top Stories Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery byTim AllenJuly 28, 2025
Financial Top Stories Carlsmed Announces Launch of Initial Public Offering byJosh SandbergJuly 16, 2025
Spine Top Stories Carlsmed Adds Industry Veteran, Kevin O’Boyle, to Board of Directors byJosh SandbergOctober 8, 2024
Financial Spine Carlsmed Announces Favorable Medicare Reimbursement Decision for Spinal Fusions with Custom-Made Anatomically Designed Devices byJosh SandbergAugust 5, 2024
Financial Spine Carlsmed Raises $52.5M in Series C Financing to Advance Personalized Spine Surgery byJosh SandbergMarch 18, 2024
Regulatory Spine FDA Grants Second Breakthrough Device Designation for Carlsmed Technology byJosh SandbergSeptember 20, 2023
